Zacks Investment Research Lowers Cross Country Healthcare (CCRN) to Sell
Zacks Investment Research cut shares of Cross Country Healthcare (NASDAQ:CCRN) from a hold rating to a sell rating in a report issued on Tuesday morning.
According to Zacks, “Cross Country Healthcare, Inc. is a national leader in providing innovative healthcare workforce solutions and staffing services. Their diverse client base includes both clinical and nonclinical settings, servicing acute care hospitals, physician practice groups, outpatient and ambulatory-care centers, nursing facilities, both public schools and charter schools, rehabilitation and sports medicine clinics, government facilities, and homecare. They are able to place clinicians on travel and per diem assignments, local short-term contracts and permanent positions. They are a market leader in providing flexible workforce management solutions, which include managed services programs (MSP), internal resource pool consulting and development, electronic medical record (EMR) transition staffing, recruitment process outsourcing, predictive modeling and other outsourcing and consultative services. “
CCRN has been the topic of several other research reports. BMO Capital Markets lowered Cross Country Healthcare from an outperform rating to a market perform rating and set a $13.00 target price on the stock. in a research note on Thursday, August 2nd. ValuEngine raised Cross Country Healthcare from a sell rating to a hold rating in a research note on Friday, July 6th. Barrington Research reissued a buy rating and set a $15.00 target price on shares of Cross Country Healthcare in a research note on Tuesday, May 22nd. Credit Suisse Group decreased their target price on Cross Country Healthcare from $11.50 to $9.00 and set a neutral rating on the stock in a research note on Thursday, August 2nd. Finally, Cantor Fitzgerald reissued a hold rating and set a $10.00 target price (down previously from $11.00) on shares of Cross Country Healthcare in a research note on Wednesday, August 1st. Two investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of Hold and a consensus price target of $13.14.
Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, August 1st. The business services provider reported $0.05 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.06 by ($0.01). Cross Country Healthcare had a return on equity of 7.90% and a net margin of 4.39%. The firm had revenue of $204.57 million for the quarter, compared to analyst estimates of $209.29 million. During the same period in the previous year, the company posted $0.16 EPS. Cross Country Healthcare’s revenue was down 2.3% on a year-over-year basis. equities analysts forecast that Cross Country Healthcare will post 0.24 earnings per share for the current fiscal year.
In related news, General Counsel Susan E. Ball purchased 5,091 shares of Cross Country Healthcare stock in a transaction on Thursday, August 9th. The shares were bought at an average price of $9.65 per share, with a total value of $49,128.15. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Thomas C. Dircks purchased 11,000 shares of Cross Country Healthcare stock in a transaction on Wednesday, August 8th. The stock was bought at an average cost of $9.07 per share, for a total transaction of $99,770.00. Following the transaction, the director now directly owns 134,595 shares in the company, valued at $1,220,776.65. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 37,341 shares of company stock worth $344,203. 3.40% of the stock is owned by corporate insiders.
Hedge funds have recently bought and sold shares of the business. Koch Industries Inc. acquired a new stake in Cross Country Healthcare in the 1st quarter valued at about $117,000. Alambic Investment Management L.P. acquired a new stake in Cross Country Healthcare in the 2nd quarter valued at about $122,000. Aperio Group LLC acquired a new stake in Cross Country Healthcare in the 1st quarter valued at about $133,000. Renaissance Technologies LLC acquired a new stake in Cross Country Healthcare in the 4th quarter valued at about $156,000. Finally, Barclays PLC raised its position in Cross Country Healthcare by 118.6% in the 1st quarter. Barclays PLC now owns 12,283 shares of the business services provider’s stock valued at $136,000 after purchasing an additional 6,665 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors.
About Cross Country Healthcare
Cross Country Healthcare, Inc provides healthcare staffing, recruiting, and workforce solutions in the United States. The company operates in three segments: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, branch-based local nurses, and allied staffing; short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and travel allied professionals on long-term contract assignments.
Read More: Google Finance Portfolio
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.